• Candela (Wayland, Massachusetts) reported the release of the Serenity Pro system. The system provides users with automatic contact sensing technology with single touch laser activation. The Serenity Pro system relies on pneumatic skin flattening (PSF) to inhibit pain during laser or light-based aesthetic treatments. Candela received the FDA clearance for the Serenity device using the PSF technology for pain reduction in October 2007. Candela makes products to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies.

• CeloNova BioSciences (Newnan, Georgia) reported results from the Atlanta study of the Catania Coronary Stent System with NanoThin Polyzene-F at the 20th annual International Symposium on Endovascular Therapy. Features of the Catania include early, complete vessel healing, as early as 30 days; patients can discontinue dual anti-platelet therapy after only one month; protection from stent thrombosis; and the Polyzene-F surface treatment is bacterial-resistant. CeloNova specializes in products using its material, Polyzene-F.